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Abstract
Background: DNA methylation can regulate gene expression by modulating the interaction between DNA and
proteins or protein complexes. Conserved consensus motifs exist across the human genome (“predicted
transcription factor binding sites”: “predicted TFBS”) but the large majority of these are proven by chromatin
immunoprecipitation and high throughput sequencing (ChIP-seq) not to be biological transcription factor binding
sites (“empirical TFBS”). We hypothesize that DNA methylation at conserved consensus motifs prevents
promiscuous or disorderly transcription factor binding.
Results: Using genome-wide methylation maps of the human heart and sperm, we found that all conserved
consensus motifs as well as the subset of those that reside outside CpG islands have an aggregate profile of
hyper-methylation. In contrast, empirical TFBS with conserved consensus motifs have a profile of hypo-methylation.
40% of empirical TFBS with conserved consensus motifs resided in CpG islands whereas only 7% of all conserved
consensus motifs were in CpG islands. Finally we further identified a minority subset of TF whose profiles are either
hypo-methylated or neutral at their respective conserved consensus motifs implicating that these TF may be
responsible for establishing or maintaining an un-methylated DNA state, or whose binding is not regulated by
DNA methylation.
Conclusions: Our analysis supports the hypothesis that at least for a subset of TF, empirical binding to conserved
consensus motifs genome-wide may be controlled by DNA methylation.
Background
DNA methylation is a well-studied component of epige-
netics that, in the mammalian system, involves the 5’
covalent modification of cytosine nucleotides by a methyl
group. In humans, cytosine methylation almost always
occurs in the context of a CG di-nucleotide, except in
undifferentiated cells where methylation was recently
identified in cytosines that do not precede guanines
(non-CG methylation) [1,2]. Regions of high CG density,
termed “CpG islands” are usually un-methylated and
found mainly in the 5’ promoter ends of genes. However
high resolution maps of genome-wide methylation now
show that cytosine methylation occurs throughout the
genome, particularly in bodies of highly expressed genes
[3], and up to 4.25% of cytosines in the human genome
are methylated [1]. Although the functional difference
between CG and non-CG methylation requires further
investigation, it is clear that DNA methylation itself
significantly regulates gene expression and affects cellu-
lar processes in disease and development [4]. For
example, genome-wide methylation is altered during
aging [5-7] and malignant transformation [8], and
recent evidence supports the notion that methylation
can be modulated by diet and environment [9-11].
Moreover evidence of rapid and dynamic DNA methy-
lation/de-methylation in vivo [12,13] challenges the
conventional view that DNA methylation is a stable or
permanent epigenetic mark.
Mechanisms to explain aberrant de novo methylation
in these contexts include (a) targeted recruitment of
DNA methyl-transferases by cis-acting factors such as
G9a or EZH2 [14], or (b) loss of boundaries or “protec-
tive” transcription factors leading to the spread of DNA
methylation into affected regions in the genome [15,16].
Indeed several non-redundant sequences matching the
consensus motifs for transcription factors such as SP1
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have been identified at sites that are resistant to de novo
methylation in cancer [17]. De novo methylated CpG
islands in cancer however were characterized by the lack
of sequence motif combinations and the absence of acti-
vating TF binding [17].
Conversely, the classical mechanism by which DNA
methylation regulates transcription is through altered
accessibility of transcription factor complexes to their
cognate DNA binding sites [4,18]. This mechanism is
supported by many locus-specific examples [19,20] but
one that links the mechanism to environmental influ-
ences is the rodent model of maternal grooming [10].
“Highly groomed” neonates developed hypo-methylation
in the first exon of the glucocorticoid receptor gene
which in turn permits binding of the transcription factor
NGFI-A to this DNA regulatory region and up-regulates
glucocorticoid receptor expression [10]. In contrast, “les-
ser groomed” neonates developed methylation in the
same DNA regulatory sequence with corresponding
inhibition of NGFI-A binding and down-regulation of
glucocorticoid receptor expression.
Conserved consensus motifs have been predicted for
transcription factor binding across the human genome,
and empirical transcription factor binding sites (TFBS)
have been determined biologically using the genome-
wide technique which couples chromatin immunopreci-
pitation and high throughput sequencing (ChIP-seq). We
have previously examined the genome-wide methylome
of human hearts [21] and sperm [22]. We therefore set
out to analyze the methylation state of TFBS in these
methylation maps.
Results
Conserved transcription factor consensus motifs
(predicted TFBS) are hyper-methylated
We analyzed genome-wide DNA methylation profile in
4 normal adult human hearts (a post-mitotic organ) and
human sperm (germ cell) by employing the technique of
MeDIP-seq [22]. Analysis of our MeDIP-seq datasets
was performed using the Bayesian deconvolution algo-
rithm called BATMAN [22]. Using BATMAN we
assigned methylation scores across the genome for
hearts and sperm. Because we hypothesized that the
interaction between transcription factor complexes and
their cognate DNA binding sites is modulated and influ-
enced by methylation of cytosines within the DNA
sequence [4,18], we examined methylation profiles at
genome-wide sites of transcription factor binding.
First, we made use of a computational dataset of tran-
scription factor motifs where locations of motifs were
determined based on a score which met the threshold
for its conserved binding matrix in the alignment for
all 3 species: human, rat and mouse (HMR) http://www.
gene-regulation.com. Score and threshold were computed
with the Transfac Matrix Database (v7.0), created by
Biobase, and are currently found on the UCSC genome
web browser (HMR Conserved TFBS, we called “set 1”,
Figure 1). We observed a profile of increased average
methylation, centred on the predicted TFBS at
3,749,417 locations where the consensus motifs for 106
transcription factor families were conserved (Figure 2A,
Table 1 for list of 106 transcription factor families). A
similar methylation profile was found for the same
3,749,417 genomic locations in sperm cells (Figure 2B).
In contrast, a separate control analysis performed with a
set of random genomic locations (N = 20,982, we called
“set 2”, Figure 1) showed no modulation in the methy-
lation profile across random genomic locations in both
hearts and sperm (Figures 2C and 2D). When examined
in further detail for each individual TF, the large major-
ity of TF showed a hyper-methylation profile in both
hearts and sperm (Table 1) but a smaller proportion
showed a variation of hypo-methylation pattern in both
tissues, an opposite pattern in either, or a neutral methyla-
tion pattern. Although the latter analysis implicates the
possibility that binding of sub-groups of transcription fac-
tors are variably affected by DNA methylation pattern,
and differences between hearts and sperm may exist for
specific sets of TF, the aggregate hyper-methylation pro-
file in the former analysis suggests that conserved con-
sensus TF motifs are mainly hyper-methylated.
Empirical TFBS with conserved consensus motifs are
hypo-methylated
Empirical or bona fide genome-wide sites of transcrip-
tion factor binding are now determined by ChIP-seq
[23] and the ENCODE consortium http://www.genome.
gov/10005107 has now performed ChIP-seq for at least
Figure 1 Datasets of genomic locations. Set 1: Predicted TFBS
based on conserved consensus motifs for 106 transcription factor
families (N = 3,749,417). Set 2: Random genomic locations (N =
20,982). Set 3: Predicted TFBS for 17 transcription factor families (N
= 771,221). Set 4: Biologically proven TFBS (empirical TFBS by ChIP-
seq) with conserved consensus motifs (N = 40,876).
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17 different TF. We therefore examined predicted TFBS
(HMR Conserved TFBS) for these 17 TF (see Table 2
for the list of these 17 TF). At the locations of predicted
TFBS for this subset of 17 TF (N = 771,221, we called
“set 3”, Figure 1), a hyper-methylation profile (Figures
3A and 3B) was again found in both hearts and sperm.
Next we compared predicted TFBS (HMR Conserved
TFBS) to empirical TFBS (ENCODE ChIP-seq) for the
same 17 TF. This revealed that only 40,876 locations
were both predicted TFBS and empirical TFBS (empiri-
cal TFBS containing the expected conserved consensus
motif, we called “set 4”, Figure 1); i.e. 3.4% (40,876 out
Figure 2 Genome-wide conserved consensus motifs (predicted TFBS) are hyper-methylated in human hearts and sperm. Methylation
scores were determined across the genome for hearts and sperm using BATMAN [21]. The profiles of these scores (A: hearts, B: sperm) were
plotted against locations of conserved consensus motifs for 106 transcription factor families centred on the predicted TF binding site (based
on co-ordinates obtained from the UCSC genome web browser: TFBS Conserved track; “set 1”, N = 3,749,417 locations). Methylation profile
at random genomic locations was analyzed as a negative control and reflects a “neutral” methylation pattern at these locations (“set 2”,
N = 20,982).
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of 1,187,431) of the empirical TFBS were predicted by
motif and conservation, and 5.3% (40,876 out of
771,221) of the predicted TFBS were biologically proven
TBFS as determined by ChIP-seq. In contrast to the
aggregate hyper-methylation profile at all predicted
TFBS ("set 1”, Figures 2A and 2B) and at the subset of
17 TFBS ("set 3”, Figures 3A and 3B), predicted TFBS
that were biologically proven TFBS ("set 4”) showed an
aggregate profile of hypo-methylation in both hearts and
sperm (Figures 3C and 3D). Table 2 shows the detailed
methylation profile for each TF in “set 4”. All TF were
associated with either a hypo-methylation or neutral
profile in hearts whereas 3 out of 17 TF showed a
hyper-methylation profile in sperm. The latter detailed
analysis may reflect specific differences in empirical TF
binding between a post-mitotic organ and germ cell.
Empirical TFBS with conserved consensus motif are more
likely to reside in CpG islands than predicted TFBS
CpG islands (CGI) are CG-rich genomic regions often
located at the 5’ promoter region of genes. Since CpG
islands are largely hypo-methylated [1,2] and the interac-
tion between transcription factor complexes and DNA
may be regulated by CGI/promoter methylation, we asked
what proportion of our sets of genomic locations corre-
sponded to CGI. Only 7% of the subset of 17 predicted
TFBS (i.e. 7% of “set 3”) resided in CGI, whereas 40% of
locations of empirical TFBS containing the expected con-
served consensus motif (i.e. 40% of “set 4”) were in CGI.
We therefore divided the predicted TFBS ("set 3”) into
CGI and non-CGI, and examined the methylation pro-
file for each subset. As expected, predicted TFBS in CGI
were hypo-methylated (Figures 4A and 4B), whereas
predicted TFBS outside of CGIs were hyper-methylated
(Figures 4C and 4D). This hyper-methylation profile again
suggests that where conserved consensus motifs for TF
binding exist outside of CGI, promiscuous or disorderly
TF binding may be controlled by DNA hyper-methylation.
Similarly, although empirical TFBS containing the
expected conserved consensus motif in CGI ("set 4”) were
hypo-methylated (Figures 5A and 5B), non-CGI of this
dataset showed a hyper-methylation profile in sperm
(Figure 5D) and a neutral methylation profile in hearts
(Figure 5C).
Discussion
Interaction between DNA and proteins or protein com-
plexes can be modulated by DNA methylation. Indeed
there are examples of DNA methylation-dependent
binding for transcription factors such as CTCF [20] and
NGFI-A [10,24]. Promiscuous or disorderly transcription
factor binding may therefore be controlled by DNA
Table 1 List of 106 transcription factor families (from UCSC genome web browser, Conserved TFBS track) and their
detailed methylation profiles in hearts and sperm
SPERM
Hyper-methylated Hypo-methylated
HEART Hyper-methylated AHR-ARNT, AML1, AP, AREB6, ARP1, ATF, BACH, BRACH, CDP, CEBP, CHOP,
COMP1, COUP, CP2, CREB, EN1, ER, FAC1, GATA, GCNF, GFI1, GR, HEN1,
HMX1, HOX, HSF, HTF, IK, ISRE, LMO2COM, LUN1, LYF1, MEIS1, MIF1, MRF2,
MSX1, MYB, MYCMAX, MYOD, MYOGNF1, MZF1, NCX, NF1, NFE2, NFKB,
NRSF, OLF1, EP300, P53, PAX, PBX1, PPAR, RFX1, ROAZ, RORA, RP58, RREB1,
SEF1, SPZ1, SREBP, SRF, STAT, TAL1-E47, TCF, TGIF, USF, XBP1, YY1, ZIC, ZID
-
Hypo-methylated CETS1P54, E2F, E4BP4, EGR, ELK1, MAZR, NFY, NRF1, SRY CHX10, FOX, FREAC, LHX3, MEF2, POU,
RSRFC4, S8, HFH, SOX, SP1, TATA, TBP
Neutral BRN2, CREL, HLF, IRF, NFAT, NGFIC, NMYC, TST1 CDC5, OCT CART1, NKX, EVI1, HNF
Table 2 List of 17 transcription factor families from
ENCODE (UCSC genome web browser) and other
published sources, and their detailed methylation
profiles in hearts and sperm
Motif family Heart Sperm
E2F1 Hypo-methylated Hypo-methylated
NFY1 Hypo-methylated Hypo-methylated
YY11 Hypo-methylated Hypo-methylated
MYCMAX1 Hypo-methylated Hyper-methylated
NFKB1 Hypo-methylated Hyper-methylated
AP1 Hypo-methylated Hyper-methylated
NRSF2 Hypo-methylated Neutral
SREBP3 Hypo-methylated Neutral
SRF2 Hypo-methylated Neutral
STAT4 Hypo-methylated Neutral
TCF1 Hypo-methylated Neutral
GATA1 Neutral Hyper-methylated
NFE21 Neutral Neutral
OCT5 Neutral Neutral
SOX5 Neutral Neutral
EP3005 Neutral Neutral
TP536 Neutral Neutral
1Yale/UCD/Harvard (ENCODE).
2HudsonAlpha Institute.
3Yale/UCD/Harvard/Duke UNC/UT, Genome Institute of Singapore (GIS).
4Yale/UCD/Harvard, GIS.
5Lister et al, Nature 2009.
6GIS.
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methylation at potential binding sites throughout the
genome where there are conserved consensus motifs.
Here our global analysis largely supports this hypothesis
for TF in general. Although the possibility remains that
we are only sampling methylation profiles at these sites
of conserved consensus motifs at a single time point,
and previous or subsequent TF binding may occur as a
result of dynamic changes in DNA methylation, this
is the first genome-wide study to associate conserved
consensus motifs (predicted TFBS) with DNA hyper-
methylation. We found similar aggregate methylation
profiles for the various sets of TFBS in parallel analyses
using methylation maps from both hearts and sperm.
Analysis of all conserved consensus motifs throughout
the genome and the subset of those that reside outside
CGI showed an aggregate profile of hyper-methylation,
but detailed analysis of individual TF suggests that there
may be subsets of TF that behave differently. These may
indeed represent specific TF whose combinatorial func-
tion is to establish or maintain the un-methylated DNA
Figure 3 Predicted TFBS with conserved consensus motifs are hyper-methylated unless they are also biologically proven TFBS
(empirical TFBS). Aggregate methylation profiles for predicted TFBS with conserved consensus motifs for a subset of 17 transcription factor
families are hyper-methylated in hearts (A) and sperm (B) (N = 771,221); but hypo-methylated if they are also biologically proven TFBS (empirical
TFBS by ChIP-seq; “set 4”, N = 40,876) (C: hearts and D: sperm).
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state [15,16]. Indeed our finding of SP1 and NRF1 in
this latter group corresponds to previous reports
[16,17,25,26] proposing this function for these two TF.
We have further found that only a very small number
of predicted TFBS containing conserved consensus
motif are biologically proven TBFS (empirical TFBS).
Conversely, only a very small subset of empirical TFBS
has the expected conserved consensus motif. Most
importantly, we found that while conserved consensus
motifs without biologically proven TF binding have a
hyper-methylated profile, sites of biologically proven
TFBS have the opposite hypo-methylation profile.
Although the scales of methylation scores (% BATMAN)
in our analysis are generally narrow (e.g. Figure 2, from
trough to peak: 53.2 - 53.6%), these scores represent
composite/aggregate scores at over 3 M locations in the
genome and confidence intervals as indicated on the
graphs do not show overlap from peaks to troughs,
Figure 4 Predicted TFBS with conserved consensus motifs residing outside of CGI are hyper-methylated. Aggregate methylation profiles
for predicted TFBS with conserved consensus motifs ("set 3”) that reside in CGI (A: hearts, B: sperm), and outside of CGI (C: hearts, D: sperm)
showing that conserved consensus motifs are hypo-methylated when within CGI but hyper-methylated when outside of CGI.
Choy et al. BMC Genomics 2010, 11:519
http://www.biomedcentral.com/1471-2164/11/519
Page 6 of 10
reflecting the significance of altered methylation pat-
terns in these regions. Moreover these methylation
scores are not representative of “whole-genome” methy-
lation but only of the local regions that are being ana-
lyzed in each graph (e.g. 3, 749,417 regions in Figure 2
but a different set of 40,876 regions in Figure 3C), peak-
to-trough scores therefore differ between analyses.
Interestingly, we also found that only a very small pro-
portion of the sites of conserved consensus motif with-
out biologically proven TF binding were within CGI s
(7%); whereas a larger proportion of sites of biologically
proven TF binding were within CGIs (40%). The lack of
methylation modulation in sites of biologically proven
TF binding outside of CGIs (Figure 5C) serves as a
negative control for the other profiles of methylation
differences that we have detected, but may also indicate
that at these sites of empirical TF binding, a neutral
methylation profile allows potential TF binding. Alterna-
tively, potential TF binding at these sites may not be
regulated by DNA methylation. Most importantly and in
contrast to that, predicted consensus TFBS that are
non-CGIs maintain a significant hyper-methylation pat-
tern (Figures 4C and 4D).
Conclusions
Our data provides genome-wide evidence that the
majority of conserved consensus motifs in the human
genome are hyper-methylated, whereas biologically pro-
ven TFBS with conserved consensus motifs are hypo-
methylated. This implicates a role for DNA methylation
in preventing promiscuous or disorderly TF binding, at
least for the majority of TF.
Methods
Ethics Statement
Human myocardium was collected by a protocol approved
by Cambridgeshire Research Ethics Committee (UK) (REC
reference: 06/Q0104/64).
Human left ventricular myocardium
Left ventricular (LV) tissue was obtained from non-
donor suitable healthy male individuals involved in road
traffic accidents. At the time of donor harvest, whole
hearts were removed and transported in cold cardiople-
gic solution (cardioplegia formula and Hartmann’s solu-
tion) similar to the procedure described before at
Imperial College, London [27]. Following analysis by a
cardiovascular pathologist, left ventricular segments
were cut and immediately snap frozen.
Genomic DNA isolation
Genomic DNA was isolated from LV samples using the
Genomic DNA Buffer Set and Anionic columns (Qia-
gen, Crawley, UK). Samples (200 mg) were homogenized
in G2 Lysis Buffer containing 80 μg/ml RNaseA, using a
hand-held homogenizer (Polytron, Switzerland), and
thereafter digested with 1 mg/ml Proteinase K (Roche
Diagnostics, Burgess Hill, UK) overnight. Fully digested
samples were centrifuged at 5000 μg for 10 min and
gDNA was isolated from the supernatant using Genomic
tip-500/G anionic columns (Qiagen) according to manu-
facturer’s instructions. Integrity and purity of genomic
DNA (gDNA) from each tissue was verified by Nano-
drop (Thermo Scientific, Wilmington, DE) and the
QIAxcel system (Qiagen).
Methylated-cytosine DNA Immunoprecipitation - high
throughput sequencing (MeDIP-seq)
Genomic DNA was sheared × 3 for 10 min each time
using a Bioruptor probe (Diagenode, Belgium) on ice at
High setting (30 sec On, 30 sec Off), and passed through
Qiagen QIAprep Spin columns. The extent of shearing
was confirmed by running 300 ng of each sample on
1.5% agarose gel. All samples were sheared to the same
extent, ranging from 100 - 500 bp with the majority of
fragments at 200 bp.
Using the Illumina DNA Sample Prep Kit (FC-102-
1001-1, Essex, UK), 5 μg of each sheared gDNA sample
was end-repaired, adenosine-bases were added to blunt
ends and respective adaptors were ligated to DNA frag-
ments, according to manufacturer’s instructions. After
each step, samples were cleaned using QIAquick Spin
columns (Qiagen). Subsequently, samples were heated at
95°C for 10 min and immediately cooled on ice for 10
min. 2.2 μg of single-stranded gDNA was used for
MeDIP and the rest stored at -20°C as the input.
MeDIP was performed as previously described [21].
Briefly, this was done using 7.5 μg of 5’methyl-cytosine
antibody (MAb-5MECYT-500, Diagenode) in 500 μl IP
buffer (10 mM sodium phosphate, pH 7.0, 140 mM
NaCl, 0.05% Triton X-100) and incubated for 2.5 h at 4°
C whilst rotating. 40 μl of 50% Protein-A agarose slurry
(sc-2001, Santa Cruz, Germany) in IP buffer was added
and incubated for further 2.5 h, whilst rotating at 4°C.
Protein-A agarose beads were subsequently spun down
and washed × 3, 10 min each time with IP buffer before
eluting with 250 μl of digestion buffer, rotating at 55°C
for another 2.5 h. Enriched methylated gDNA was puri-
fied using × 2 phenol:chloroform isolation, chloroform
wash and precipitation using NaCl. Following washes
with 70% ethanol, samples were quantified and a non-
saturating amplification was performed using Illumina
Primers 1.1 and 1.2 and 14-cycle PCR as recommended
by Illumina. Next, samples were cleaned using QIAquick
Spin columns and quantified on Bioanalyzer. 20 ng of
each sample was used to confirm enrichment of methy-
lated locus (OXT) and a concomitant depletion of un-
methylated locus (UBE2B) versus the input by qPCR, as
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previously described [21]. MeDIP samples were loaded
onto a 2% agarose gel and the 150 - 250 bp bands were
cut, and DNA eluted using Qiagen Gel extraction kit
and further quantified using Bioanalyzer. Since we used
“Illumina Library Single end Primers 1” (92 bp long), we
expected our “short libraries” to contain insert sizes to
range between 50 - 150 bp long. High throughput
sequencing was performed (GeneService, Cambridge,
UK) for each of the libraries on 2 channels of the Illu-
mina GAII machine to a sequencing depth of at least 14
mil reads of 35 bp length for each library.
Data sets, genomic features and data analysis
MeDIP-seq data of human hearts were analyzed using a
Bayesian deconvolution strategy, BATMAN (22). BAT-
MAN scores from four normal human hearts were
Figure 5 Empirical TFBS with conserved consensus motifs are hypo-methylated in CGI but have a neutral methylation pattern when
outside of CGI in the heart. Methylation profiles for empirical TFBS with conserved consensus motifs ("set 4”) that resided in CGI (A: hearts,
B: sperm), and outside CGI (C: hearts, D: sperm).
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averaged using a Perl script (written by MKC and
HGG). MeDIP-seq data of human sperm cells analyzed
using the same algorithm came from a published
resource [22]. MeDIP-seq data for normal human hearts
will be deposited in GEO (Accession number). Average
plots of methylation densities were calculated using an
algorithm previously described [28]. Transcription factor
binding motifs conserved in human/mouse/rat and not
containing repetitive elements were from UCSC Gen-
ome Browser (http://genome.ucsc.edu/; TFBS Conserved
track). ChIP-seq co-ordinates for 17 transcription factors
were obtained from ENCODE projects deposited in
UCSC Genome Browser and other published work (see
references). Intersections between datasets were com-
puted using the Table Browser in UCSC Genome Brow-
ser or BEDTools http://sourceforge.net/projects/
bedtools/ [29].
CpG island annotation
This was obtained from the UCSC Genome Browser
(annotated according to [30]). CpG islands were pre-
dicted by searching the sequence one base at a time,
scoring each dinucleotide (+17 for CG and -1 for others)
and identifying maximally scoring segments. Each seg-
ment was then evaluated for the following criteria: GC
content of 50% or greater, length greater than 200 bp,
ratio greater than 0.6 of observed number of CG dinu-
cleotides to the expected number on the basis of the
number of Gs and Cs in the segment.
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